Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
23 April 2025
Events
Rooftop Reception at IAPP Global Privacy Summit 2025
Following the first day of the International Association of Privacy Professionals’ 2025 Global Privacy Summit, Foley & Lardner’s Cybersecurity & Data Privacy team will be hosting a networking reception on the rooftop of The Delegate, conveniently located across the street from the venue.
13 March 2025
Foley Ignite
New Opportunities and Challenges for Board Directors
Foley & Lardner LLP recently co-hosted a webinar with the National Association of Corporate Directors to discuss how a new presidential administration and evolving state-driven regulations are effecting boardrooms.
27 March 2025
Events
Administrative Enforcement: Collateral Consequences of Compliance Failures
Foley partner Judy Waltz, chair of Foley’s Health Care Practice Group, is speaking in the American Health Law Association Institute (AHLA) on Medicare and Medicaid Payment Issues in the session “Administrative Enforcement: Collateral Consequences of Compliance Failures” on March 27.